|
Population
a
|
|
|
| Physicians (MDs, DOs) |
13 (87%) |
Baicus et al., 2017; Brundage et al., 2011; Elting and Bodey, 1991; Elting et al., 1999; Garcia-Retamero et al., 2016; Garcia-Retamero et al., 2020; Kujipers et al., 2016; Mazur and Hickam, 1993; Moynihan et al., 2018; Petit-Moneger et al., 2017; Raina et al., 2005; Snyder et al., 2017; Zikmund-Fisher et al., 2019
|
| Other healthcare providers (NPs, PAs) |
3 (20%) |
Elting and Bodey, 1991;
Kujipers et al., 2016, Snyder et al., 2017; |
| Medical students/residents |
3 (20%) |
Friederichs et al., 2014; Mazur and Hickam, 1993; Windish et al., 2007
|
|
Type of data in display
a
|
|
|
| Risk of disease/adverse effects |
3 (20%) |
Baicus et al., 2017; Garcia-Retamero et al., 2016; Garcia-Retamero et al., 2020; |
| Health-related quality of life/PROs |
3 (20%) |
Brundage et al., 2011; Kujipers et al., 2016; Snyder et al., 2017; |
| Mortality/survival |
3 (20%) |
Elting and Bodey, 1991;
Mazur and Hickam, 1993; Windish et al., 2007
|
| Treatment benefit/effectiveness |
2 (13%) |
Elting et al., 1999; Zikmund-Fisher et al., 2019
|
| Changes over time/presentation of multiple time periods |
2 (13%) |
Baicus et al., 2017; Brundage et al., 2011
|
| Disease or infection rates |
2 (13%) |
Elting and Bodey, 1991; Friederichs et al., 2014
|
| Meta-analysis outcomes |
1 (7%) |
Raina et al., 2005
|
| Other (test sensitivity, unspecified clinical trial data, clinical practice feedback data) |
3 (20%) |
Friederichs et al., 2014; Moynihan et al., 2018; Petit-Moneger et al., 2017
|
|
Data display comparisons
a
|
|
|
| Types of visual display (e.g., bar chart, line graph, icon array, table) |
6 (40%) |
Brundage et al., 2011; Elting and Bodey, 1991; Elting et al., 1999; Kujipers et al., 2016; Petit-Moneger et al., 2017; Zikmund-Fisher et al., 2019
|
| Visual vs. no-visual (narrative, numbers) |
4 (27%) |
Elting and Bodey, 1991;
Friederichs et al., 2014; Garcia-Retamero et al., 2016; Garcia-Retamero et al., 2020
|
| Display formatting or presentation (e.g., color, shading, gradient, threshold lines) |
3 (20%) |
Kujipers et al., 2016; Snyder et al., 2017; Zikmund-Fisher et al., 2019
|
| Framing (positive vs. negative response) |
1 (7%) |
Elting et al., 1999
|
| Length of time (e.g., 1-year vs. 5-year risk) |
1 (7%) |
Baicus et al., 2017
|
| Additive information (e.g., single vs. multiple displays) |
1 (7%) |
Baicus et al., 2017
|
| Other characteristics (varied denominators, area under curve, type of measure) |
4 (27%) |
Garcia-Retamero et al., 2020; Hickam, 1993; Mazur and Raina et al., 2005; Petit-Moneger et al., 2017
|
| Not applicable |
3 (20%) |
Brundage et al., 2011; Moynihan et al., 2018; Windish et al., 2007
|
|
Study Design
a
|
|
|
| Studies with randomization |
|
|
| Between-subjects comparison |
4 (27%) |
Baicus et al., 2017; Friederichs et al., 2014; Garcia-Retamero et al., 2016; Garcia-Retamero et al., 2020
|
| Within-subjects comparison |
4 (27%) |
Elting and Bodey, 1991; Mazur and Hickam, 1993; Petit-Moneger et al., 2017; Zikmund-Fisher et al., 2019
|
| Both between- and within-subjects comparisons |
3 (20%) |
Elting et al., 1999; Raina et al., 2005; Snyder et al., 2017
|
| Studies without randomization |
|
|
| Cross-sectional survey |
2 (13%) |
Kujipers et al., 2016; Windish et al., 2007
|
| Qualitative interviews |
2 (13%) |
Brundage et al., 2011; Moynihan et al., 2018; Snyder et al., 2017
|
|
Medical condition context
|
|
|
| Cancer |
5 (33%) |
Brundage et al., 2011; Elting and Bodey, 1991; Elting et al., 1999; Kujipers et al., 2016; Snyder et al., 2017; |
| Other or general |
10 (67%) |
Baicus et al., 2017; Friederichs et al., 2014; Garcia-Retamero et al., 2016;
Garcia-Retamero et al., 2020; Mazur and Hickam, 1993; Moynihan et al., 2018; Petit-Moneger et al., 2017; Raina et al., 2005; Windish et al., 2007; Zikmund-Fisher et al., 2019
|
|
Setting
|
|
|
| U.S. |
7 (47%) |
Elting and Bodey, 1991; Elting et al., 1999; Mazur and Hickam, 1993; Moynihan et al., 2018; Snyder et al., 2017; Zikmund-Fisher et al., 2019; Windish et al., 2007
|
| Europe |
6 (40%) |
Baicus et al., 2017; Friederichs et al., 2014; Garcia-Retamero et al., 2016; Garcia-Retamero et al., 2020; Kujipers et al., 2016; Petit-Moneger et al., 2017
|
| Canada |
2 (13%) |
Brundage et al., 2011; Raina et al., 2005
|
